The global follow-on biologics market is gaining momentum as a
response to the expiry of a number of patents on key biologicals and
growing consumer demand for cost-effective biologicals treatment.
Even though Europe has led the regulatory process for enhancing the
availability of follow-on biologics, approvals in the U.S. for
biologicals have lagged behind those in the international community.
The research report maps all the crucial aspects of the biologicals
in oncology market. It covers market projections, prominent industry
trends, and market drivers and restraints of biologicals. In
addition, the report provides a snapshot of the research and
development activities in the biologicals in oncology market. These
R&D projects will influence the biologicals markets significantly
and will set the pace of the market during the forecast period of
2013 to 2019.
The global biological drugs market is estimated to be worth
US$287,139.7 million by the end of 2020. North America leads the
biologicals in oncology market, followed by Europe and Asia Pacific.
The primary driver of the biologicals in oncology market is
increasing government support to improve healthcare conditions. Among
the registered therapies of biologicals in oncology, vaccine therapy,
and monoclonal antibodies therapy generate the major chunk of
revenue, as they increase the chances of uptake of cancerous tissue.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2310
Biologicals to treat cancer involve bacteria or vaccines which
stimulate the body’s defense response against cancer cells. The
biologicals in oncology industry is segmented according to the type
of biological, development state, and pathway mapping used for cancer
therapy investigation. In the coming years, the biologicals in
oncology market will experience rapid growth as the prevalence of the
cancer accelerates worldwide.
However, the major inhibitor for the market is the fear of side
effects of the biological drugs treatment. According to cancer.gov,
the side effects associated with various biological therapies can
differ according to the treatment types. Some of these include pain,
swelling, redness, soreness, itchiness, and rashes at the site of
injection.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=2310<ype=S
Over 880 enterprises with their partners are involved in developing
approximately 1,500 drugs in research and development projects to
treat 132 cancer types. Some of the companies and institutes that are
involved in clinical trials and manufacturing of biologicals are F.
Hoffmann – La Roche, Limited, Astex Therapeutics, Prometheus
Therapeutics and Diagnostics, Merck and Company, Northwest
Biotherapeutics, Immunovative Therapies, The University of Bologna
Medical School, NewLink Genetics Corporations, Rui Jin Hospital,
National Institute of Mental Health, Hadassah University Hospital,
and Peking University People’s Hospital.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment